METAGUIDEX

Unknown (Unknown)

Start Date End Date Funded Value Relevance

CSV

25 50 100

£209,960

May 21 - May 22

Developing MetaGuideX, a rapid test for determining metastatic status in breast cancer.

Innovate UK award to METAGUIDEX and Ryan Pink

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}